Test Reports

Cxbladder test reports provide actionable results that are intended to aid in the detection of Urothelial Carcinoma (UC) when used in conjunction with standard clinical assessment.

Each report provides a validated Cxbladder score based on the measured quantity of five mRNA biomarkers.

Cxbladder Triage Results Interpretation

 

The Cxbladder Triage score ranges from 0.0 to 10.0. Using a cut-off of 4.0, it identifies patients who have a low probability of having UC.  

Cxbladder Detect Results Interpretation

 

The Cxbladder Detect score ranges from 0.00 to 1.00.

NORMAL Gene Expression Score (< 0.12): A score of <0.12 has a Negative Predictive Value (NPV) of 97%. High probability of NO UC.

ELEVATED Gene Expression Score (0.12 ≤ score < 0.23): A score of 0.12 ≤ score < 0.23 has an NPV of 94%. Low probability of UC, however a change in the pattern of gene expression of the biomarkers from what is normal suggests further clinical evaluation

HIGH Gene Expression Score (≥ 0.23): A score of ≥ 0.23 has a Positive Predictive Value (PPV) of 68%. High probability of UC.

 

Cxbladder Monitor Results Interpretation

 

A Cxbladder Monitor score of <3.5 has a Negative Predictive Value (NPV) of 97%, and sensitivity of 93%. This indicates a low probability of recurrent UC.

A Cxbladder Monitor score of ≥ 3.5 indicates that a clinician-directed protocol to determine the presence of recurrent UC, is warranted.

The report tracks Cxbladder Monitor scores over time.

Last Updated: 24 Aug 2021 10:52 pm